Article Versions Notes

Megiorni F, Camero S, Pontecorvi P, Camicia L, Marampon F, Ceccarelli S, Anastasiadou E, Bernabò N, Perniola G, Pizzuti A, et al. OTX015 Epi-Drug Exerts Antitumor Effects in Ovarian Cancer Cells by Blocking GNL3-Mediated Radioresistance Mechanisms: Cellular, Molecular and Computational Evidence. Cancers. 2021; 13(7):1519. https://doi.org/10.3390/cancers13071519

Megiorni, Francesca, Simona Camero, Paola Pontecorvi, Lucrezia Camicia, Francesco Marampon, Simona Ceccarelli, Eleni Anastasiadou, Nicola Bernabò, Giorgia Perniola, Antonio Pizzuti, and et al. 2021. "OTX015 Epi-Drug Exerts Antitumor Effects in Ovarian Cancer Cells by Blocking GNL3-Mediated Radioresistance Mechanisms: Cellular, Molecular and Computational Evidence" Cancers 13, no. 7: 1519. https://doi.org/10.3390/cancers13071519

Megiorni, F., Camero, S., Pontecorvi, P., Camicia, L., Marampon, F., Ceccarelli, S., Anastasiadou, E., Bernabò, N., Perniola, G., Pizzuti, A., Benedetti Panici, P., Tombolini, V., & Marchese, C. (2021). OTX015 Epi-Drug Exerts Antitumor Effects in Ovarian Cancer Cells by Blocking GNL3-Mediated Radioresistance Mechanisms: Cellular, Molecular and Computational Evidence. Cancers, 13(7), 1519. https://doi.org/10.3390/cancers13071519